داروسازی لقمان
دلقما | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 9,830 1.34
Close Price: 9,730
Balance Sheet
AGM
Interim
2026/07/12 Fiscal Year 2026/03/2012 Month | 2025/07/19 Fiscal Year 2025/03/2012 Month | 2024/07/21 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 2.411 Trillion | 974.935 Billion | 162.682 Billion | |
Trade Receivables | 17.873 Trillion | 9.594 Trillion | 6.536 Trillion | |
Prepayments | 999.106 Billion | 392.575 Billion | 847.293 Billion | |
Raw Materials & Packaging Inventory | 2.86 Trillion | 1.648 Trillion | 1.418 Trillion | |
Work-in-Progress Inventory | 733.177 Billion | 209.425 Billion | 94.481 Billion | |
Finished Goods Inventory | 380.346 Billion | 664.73 Billion | 266.715 Billion | |
Spare Parts Inventory | 234.827 Billion | 139.741 Billion | 101.949 Billion | |
Goods in Transit | 340.552 Billion | - | - | |
Inventories | 4.549 Trillion | 2.662 Trillion | 1.882 Trillion | |
Total Current Assets | 25.833 Trillion | 13.624 Trillion | 9.427 Trillion | |
Long-Term Investments | 1.476 Trillion | 2.821 Trillion | 2.821 Trillion | |
Long-Term Trade Receivables | 73.369 Billion | 6.591 Billion | 11.109 Billion | |
Intangible Assets | 66.951 Billion | 70.219 Billion | 70.219 Billion | |
Property, Plant & Equipment | 5.588 Trillion | 5.239 Trillion | 5.288 Trillion | |
Net Fixed Assets | 5.588 Trillion | 5.239 Trillion | 5.288 Trillion | |
Total Non-Current Assets | 7.204 Trillion | 8.137 Trillion | 8.19 Trillion | |
Total Assets | 33.036 Trillion | 21.76 Trillion | 17.618 Trillion | |
Trade Payables | 5.771 Trillion | 5.433 Trillion | 4.086 Trillion | |
Advances Received | 49.572 Billion | 10.629 Billion | 19.906 Billion | |
Income Tax Provision | 1.376 Trillion | 365.475 Billion | 298.838 Billion | |
Proposed & Payable Dividends | 344.994 Billion | 264.076 Billion | 164.136 Billion | |
Current Borrowings | 7.913 Trillion | 3.946 Trillion | 1.772 Trillion | |
Total Current Liabilities | 15.454 Trillion | 10.019 Trillion | 6.341 Trillion | |
Employee Termination Benefits Provision | 529.893 Billion | 394.86 Billion | 277.428 Billion | |
Total Non-Current Liabilities | 529.893 Billion | 394.86 Billion | 277.428 Billion | |
Total Liabilities | 15.984 Trillion | 10.414 Trillion | 6.618 Trillion | |
Capital | 10.235 Trillion | 6.735 Trillion | 6.735 Trillion | |
Retained Earnings | 6.223 Trillion | 4.34 Trillion | 4.036 Trillion | |
Legal Reserve | 582.924 Billion | 259.242 Billion | 216.641 Billion | |
Other Reserves | 11.58 Billion | 11.58 Billion | 11.58 Billion | |
Total Equity | 17.052 Trillion | 11.346 Trillion | 11 Trillion | |
Total Liabilities & Equity | 33.036 Trillion | 21.76 Trillion | 17.618 Trillion | |
Approved Capital | 10.235 Trillion | 6.735 Trillion | 6.735 Trillion | |
Approved Retained Earnings | 2.988 Trillion | 3.573 Trillion | 3.531 Trillion | |
Approved Legal Reserve | 582.924 Billion | 259.242 Billion | 216.641 Billion | |
Other Approved Reserves | 11.58 Billion | 11.58 Billion | 11.58 Billion | |
Total Approved Equity (at AGM) | 13.818 Trillion | 10.579 Trillion | 10.494 Trillion | |
Revaluation Surplus of Property, Plant and Equipment | 40 Million | 40 Million | 40 Million |